Greg O’Brien is an award-winning investigative reporter who’s written for many national and regional publications, including The Washington Post. He was diagnosed with early onset Alzheimer’s at the age of 59 after a traumatic … [Read more...]
What the New Enhanced Auditing of Medicare Advantage Means for You
January 27, 2023 by Leave a Comment
Q. I remember reading in one of your articles this past fall that some of the largest Medicare Advantage insurers are submitting inflated bills and that it’s one of the reasons everything is so much more expensive for plan … [Read more...]
Critter Corner: Will the Inflation Reduction Act Affect Seniors on Medicare?
January 27, 2023 by Leave a Comment
Dear Angel, I heard about the Inflation Reduction Act and am hoping it will help Americans during this challenging time. With the rise in cost of everything these days, we can certainly use all the help we can get. What I’m … [Read more...]
The ‘Benjamin Button’ Effect: If Scientists Can Reverse Aging in Mice, Can They Do the Same for Humans?
January 24, 2023 by Leave a Comment
Fourteen years ago, the movie “The Curious Case of Benjamin Button” was released. In the movie, Benjamin Button (Brad Pitt) begins life as an elderly man in a New Orleans nursing home and ages in reverse. Twelve years later, he … [Read more...]
Using LLCs and Asset Protection Trusts for Asset Protection of Rental Property
January 21, 2023 by Leave a Comment
Q. I own a rental property in Springfield, Virginia, that's just in my name. I heard the best way to protect my assets, should I be subject to a lawsuit, is by creating an LLC for my rental and deeding the house to the LLC. But I … [Read more...]
Critter Corner: Are You Celebrating Life This January?
January 20, 2023 by Leave a Comment
Dear Raider, As we embark on the first few weeks of the New Year, I decided that 2023 will be my year to make a change and add more positivity and gratitude to my life. I heard that January was Celebration of Life Month. What … [Read more...]
FDA Approves New Alzheimer’s Drug That Slows Progression of the Disease
January 17, 2023 by Leave a Comment
On January 6, 2023, the Food and Drug Administration approved the new Alzheimer’s drug lecanemab, which has been shown in clinical trials to slow cognitive decline in patients with mild cognitive impairment or early Alzheimer’s … [Read more...]
